Celularity Statistics
Share Statistics
Celularity has 23.95M
shares outstanding. The number of shares has increased by -79.94%
in one year.
Shares Outstanding | 23.95M |
Shares Change (YoY) | -79.94% |
Shares Change (QoQ) | -64.85% |
Owned by Institutions (%) | 0.01% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 122 |
FTD / Avg. Volume | 0.59% |
Short Selling Information
The latest short interest is 84.84K, so 0% of the outstanding
shares have been sold short.
Short Interest | 84.84K |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 9.81 |
Valuation Ratios
The PE ratio is -0.79 and the forward
PE ratio is null.
Celularity's PEG ratio is
0.01.
PE Ratio | -0.79 |
Forward PE | n/a |
PS Ratio | 0.84 |
Forward PS | n/a |
PB Ratio | 5.15 |
P/FCF Ratio | -6.94 |
PEG Ratio | 0.01 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Celularity.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38,
with a Debt / Equity ratio of 3.29.
Current Ratio | 0.38 |
Quick Ratio | 0.28 |
Debt / Equity | 3.29 |
Debt / EBITDA | -0.76 |
Debt / FCF | -4.42 |
Interest Coverage | 6.12 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $451,833.33 |
Profits Per Employee | $-482,433.33 |
Employee Count | 120 |
Asset Turnover | 0.41 |
Inventory Turnover | 1.64 |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 150% in the
last 52 weeks. The beta is 0.61, so Celularity's
price volatility has been higher than the market average.
Beta | 0.61 |
52-Week Price Change | 150% |
50-Day Moving Average | 0.05 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 47.89 |
Average Volume (20 Days) | 20,624 |
Income Statement
In the last 12 months, Celularity had revenue of 54.22M
and earned -57.89M
in profits. Earnings per share was -2.64.
Revenue | 54.22M |
Gross Profit | 45.33M |
Operating Income | -38.36M |
Net Income | -57.89M |
EBITDA | -38.36M |
EBIT | n/a |
Earnings Per Share (EPS) | -2.64 |
Full Income Statement Balance Sheet
The company has 738K in cash and 29.03M in
debt, giving a net cash position of -28.3M.
Cash & Cash Equivalents | 738K |
Total Debt | 29.03M |
Net Cash | -28.3M |
Retained Earnings | -899.68M |
Total Assets | 132.68M |
Working Capital | -33.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -6.4M
and capital expenditures -161K, giving a free cash flow of -6.56M.
Operating Cash Flow | -6.4M |
Capital Expenditures | -161K |
Free Cash Flow | -6.56M |
FCF Per Share | -0.3 |
Full Cash Flow Statement Margins
Gross margin is 83.6%, with operating and profit margins of -70.75% and -106.77%.
Gross Margin | 83.6% |
Operating Margin | -70.75% |
Pretax Margin | -106.77% |
Profit Margin | -106.77% |
EBITDA Margin | -70.75% |
EBIT Margin | -70.75% |
FCF Margin | -12.1% |